Central unit to monitor security and affordability of pharma drugs in Goa
Panaji: In an effort to monitor prices of pharmaceutical drugs and to ensure availability of crucial medicines, the Centre has setup a Price Monitoring and...
Pharma
FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators in the US, UK, Brazil, South Africa and Japan...
CureVac reports positive preclinical data for its COVID-19 vaccine candidate, CVnCoV
CureVac N.V. (Nasdaq: CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced data from...
Deaths rattle South Korea’s seasonal flu vaccination, but authority presses ahead with free scheme
South Korea is preparing to fight two infectious diseases this winter: the novel coronavirus and the flu. But reports of deaths after flu shot vaccination...
Merck, Pfizer pneumonia vaccines running low in EU as researchers fight COVID-19: report
As COVID-19 continues to rage worldwide, health authorities worry that a perfect storm of the novel coronavirus, pneumonia and seasonal flu could overtake hospital systems....
Moderna completes enrollment of Phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273)
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today...
CDC working with Warp Speed, local jurisdictions on nationwide COVID-19 vaccine plan: official
In less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic. Concerns remain, though,...
Moderna, now wrapped on phase 3 enrollment, touts diversity of vaccine trial participants
Moderna is one step closer to a COVID-19 vaccine. Racing ahead with its candidate, mRNA-1273, the biotech has now finished enrolling the 30,000 participants needed...
Dr. Reddy’s shuts ‘key’ plants worldwide after potential cyberattack hits COVID work
As major drugmakers race to develop effective COVID-19 vaccines, a rogue’s gallery of bad state actors have been pegged behind a series of data breaches into...
Lonza plots $93M expansion to capsule manufacturing, adding billions of doses per year
When CDMO Lonza shelled out $5.5 billion for capsule maker Capsugel in 2017, it made a big bet the booming capsule market would drive revenue....